Janney Montgomery Scott LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
Janney Montgomery Scott LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2021$601,000
-67.4%
9,022
-45.7%
0.00%
-66.7%
Q1 2021$1,845,000
-15.2%
16,620
-9.2%
0.01%
-18.2%
Q4 2020$2,175,000
+26.5%
18,314
-7.1%
0.01%
+10.0%
Q3 2020$1,719,000
-18.3%
19,705
-16.0%
0.01%
-50.0%
Q2 2018$2,103,000
-29.0%
23,453
-42.0%
0.02%
-33.3%
Q1 2018$2,960,000
+4.7%
40,461
-16.9%
0.03%
+3.4%
Q4 2017$2,826,000
+22.9%
48,664
-5.1%
0.03%
+11.5%
Q3 2017$2,300,000
+17.9%
51,256
+3.8%
0.03%
+8.3%
Q2 2017$1,950,000
+182.6%
49,377
+190.3%
0.02%
+166.7%
Q1 2017$690,000
+0.6%
17,008
-0.3%
0.01%
-10.0%
Q4 2016$686,00017,0650.01%
Other shareholders
HAEMONETICS CORP shareholders Q1 2021
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders